Fidelity Investments’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-292,966
| Closed | -$1.2M | – | 5740 |
|
|
2022
Q1 | $1.2M | Sell |
292,966
-545,914
| -65% | -$1.98M | ﹤0.01% | 2744 |
|
|
2021
Q4 | $3M | Buy |
838,880
+30,953
| +4% | +$108K | ﹤0.01% | 2477 |
|
|
2021
Q3 | $2.94M | Sell |
807,927
-2,022,603
| -71% | -$8.18M | ﹤0.01% | 2489 |
|
|
2021
Q2 | $12.3M | Sell |
2,830,530
-1,007,211
| -26% | -$4.1M | ﹤0.01% | 2027 |
|
|
2021
Q1 | $15.8M | Sell |
3,837,741
-846,258
| -18% | -$3.67M | ﹤0.01% | 1878 |
|
|
2020
Q4 | $18.7M | Buy |
4,683,999
+205,231
| +5% | +$664K | ﹤0.01% | 1739 |
|
|
2020
Q3 | $12.1M | Sell |
4,478,768
-143,059
| -3% | -$396K | ﹤0.01% | 1764 |
|
|
2020
Q2 | $12.7M | Buy |
4,621,827
+1,469,190
| +47% | +$4.1M | ﹤0.01% | 1726 |
|
|
2020
Q1 | $7.44M | Sell |
3,152,637
-80,490
| -2% | -$274K | ﹤0.01% | 1789 |
|
|
2019
Q4 | $15.2M | Sell |
3,233,127
-4,800
| -0.1% | -$19.6K | ﹤0.01% | 1704 |
|
|
2019
Q3 | $10.8M | Sell |
3,237,927
-242,000
| -7% | -$797K | ﹤0.01% | 1794 |
|
|
2019
Q2 | $11.4M | Buy |
3,479,927
+47,273
| +1% | +$137K | ﹤0.01% | 1836 |
|
|
2019
Q1 | $10.4M | Sell |
3,432,654
-95,210
| -3% | -$309K | ﹤0.01% | 1853 |
|
|
2018
Q4 | $9.6M | Sell |
3,527,864
-49,291
| -1% | -$162K | ﹤0.01% | 1824 |
|
|
2018
Q3 | $12M | Sell |
3,577,155
-63,645
| -2% | -$197K | ﹤0.01% | 1877 |
|
|
2018
Q2 | $9.39M | Buy |
3,640,800
+1,018,300
| +39% | +$2.53M | ﹤0.01% | 1964 |
|
|
2018
Q1 | $5.77M | Buy |
2,622,500
+41,600
| +2% | +$93.6K | ﹤0.01% | 2117 |
|
|
2017
Q4 | $5.14M | Sell |
2,580,900
-332,787
| -11% | -$724K | ﹤0.01% | 2163 |
|
|
2017
Q3 | $9.44M | Buy |
+2,913,687
| New | +$8.99M | ﹤0.01% | 1960 |
|
|
2014
Q1 | – | Sell |
-410,000
| Closed | -$1.84M | – | 2735 |
|
|
2013
Q4 | $1.84M | Sell |
410,000
-80,500
| -16% | -$328K | ﹤0.01% | 2364 |
|
|
2013
Q3 | $1.99M | Sell |
490,500
-216,200
| -31% | -$944K | ﹤0.01% | 2348 |
|
|
2013
Q2 | $2.94M | Buy |
+706,700
| New | +$2.73M | ﹤0.01% | 2251 |
|
Other funds holding ATRS
Fidelity Investments's ATRS Position: Q2 2022 in Review
Fidelity Investments sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 292,966 shares — an estimated $1.2M sold.
Fidelity Investments first reported a position in ATRS in Q2 2013 and held it in 22 quarters. The position peaked at $18.7M in Q4 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Fidelity Investments reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Fidelity Investments sold 292,966 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.2M.
- Fidelity Investments first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 22 quarters.
- Fidelity Investments's Antares Pharma, Inc. position peaked at $18.7M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Fidelity Investments's 13F filing for Q2 2022, filed 12 Aug 2022.